Abstract
The gut hormone glucagon-like peptide-1 (GLP-1) is derived from the transcription product of the proglucagon gene in the intestinal L cells. The known physiological functions of this peptide include: increases insulin and decreases glucagon secretion from the pancreas, furthermore promotes insulin sensitivity. Our research group working on diabetes and obesity, considered that it is important to develop an own specific and sensitive GLP-1 radioimmunoassay (RIA) method. The antiserum (GLP3/7), sensitive to the C-terminal region of peptide was produced by the immunization of rabbits administering GLP-1(19-37)-bovine serum albumin antigen subcutaneously. To show the antibody attachment we used iodogen method labelled mono-125I-GLP-1(19-37). GLP-1(19–37) peptide was used as standard for the RIA determination in a range of 0–1000 fm/ml. Our new RIA method was applied in an insulin resistance animal model. In the experiment Sprague-Dawley rats were treated with olanzapine (per os) 5 mg/kg body weight once a day for four weeks. Finally, in a glucose uptake experiment blood glucose and plasma GLP-1 levels were measured. After ten measurements the D50 value of the calibration curves was 15.18 ± 2.02 fmol/ml. The detection limit of our method was 0.4 fmol/ml GLP-1. The cross-reactivity studies showed that the antiserum used in our RIA method has a limited cross-reactivity with other peptides with similar structure. The difference of fasting blood glucose and GLP-1 plasma levels between control and olanzapine-treated animals were not significant, while blood glucose concentration was increased GLP-1 plasma level was significantly decreased during glucose uptake.
Similar content being viewed by others
References
Bell GI, Sanchez PR, Laybourn PJ, Najarian RC (1983) Nature 304:368
Vilsboll T (2004) Dan Med Bull 51:364
Deacon CF, Holst JJ (2009) Best Pract Res Clin Endocrinol Metab 23:425
Gautier JF, Fetita S, Sobngwi E, Salaün-Martin C (2005) Diabetes Metab 31:233
Brubaker PL (2010) Endocrinology 151:1984
Hunter WM, Greenwood FC (1962) Nature 194:495
Németh J, Vecsernyés M, Oroszi G, Balla Zs, Helyes Zs, Farkas B, Szilvássy Z (2000) J Label Compd Rad 43:855
Abdel-Ghany IY, Moustafa KA, Abdel-Bary HM, Shamsel-Din HA (2013) J Radioanal Nucl Chem 295:1273
Marchalonis JJ (1969) Biochem J 113:299
Fraker PJ, Speck JC (1978) Biochem Biophys Res Commun 80:849
Salacinski PRP, McLean C, Sykes JEC, Clement-Jones VV, Lowry PJ (1981) Anal Biochem 117:136
Németh J, Oroszi G, Jakab B, Magyarlaki M, Szilvássy Z, Rőth E, Farkas B (2002) J Radioanal Nucl Chem 251:129
Enginar H, Unak P, Biber Müftüler FZ, Lambrecht FY, Yurt Kilcar A, Yolcular S, Seyitoglu B, Medine EI, Bulduk I (2012) J Radioanal Nucl Chem 292:667
Fürjes G, Tóth GK, Peitl B, Pórszász R, Lelesz B, Sári R, Tóth A, Szilvássy Z, Németh J (2012) J Radioanal Nucl Chem 292:113
Kaiser E, Colescott RL, Bossinger CD, Cook PJ (1970) Anal Biochem 34:595
Morris BJ (1976) Clin Chim Acta 73:213
Ali MA, Sagar HA, Khatun CS, Azad AK, Begun K, Wahed II (2012) Int J Pharm Sci Res 3:416
Németh J, Varró A, Bridson J, Walker R, Dockray GJ (1992) Eur J Clin Invest 22:638
Ranu BC, Banerjee S (2005) Org Lett 7:3049
Chi Y, Gellman SH (2005) Org Lett 7:4253
Arimura A, Somogyvári-Vigh A, Miyata A, Mizeno K, Coy DH, Kitada C (1991) Endocrinology 129:2787
McGuigan JE (1968) Gastroenterology 54:1005
Yellow RS, Berson SA (1970) Gastroenterology 58:1
Stadil F, Rehfeld JF (1972) Scand J Clin Lab Invest 30:361
Pauwels S, Desmond H, Dimaline R, Dockray GJ (1986) J Clin Invest 77:376
Seet L, Fabri L, Nice EC, Baldwin GS (1987) Biomed Chromatogr 2:159
Németh J, Oroszi G, Jakab B, Schweibert I, Szolcsányi J, Szilvássy Z (2002) J Radioanal Nucl Chem 254:277
Németh J, Jakab B, Józsa R, Hollósy T, Tamás A, Lubics A, Lengvári I, Kiss P, Oberritter Z, Horváth B, Szilvásy Z, Reglődi D (2007) J Radioanal Nucl Chem 273:327
Wang J (1969) Handbook of radioactive nuclides. CPCP Press, Cleveland
Acknowledgments
This study was supported by the Hungarian National Office for Research and Technology (NKFP 07-A2-2008-0260; GOP-1.1.2-07/1-2008-0004; TÁMOP-4.2.2-08/1-2008-0014, OM-00174/2008; TÁMOP-4.2.2/B-10/1-2010-0024; GOP-1.1.1-07/1-2008-0032; GOP-1.2.1-08-2009-0023; GOP-1.1.1-11-2012-0412) and the Hungarian Scientific Research Fund (OTKA-75965).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lelesz, B., Tóth, G.K., Peitl, B. et al. Description and application of a novel glucagon-like peptide-1 (GLP-1) radioimmunoassay. J Radioanal Nucl Chem 299, 157–164 (2014). https://doi.org/10.1007/s10967-013-2751-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-013-2751-0